Recent short interest data for the 10/31/2014 settlement date shows an increase in short interest for shares of Regulus Therapeutics Inc. (RGLS). As of October 31, the short interest for the biopharmaceutical company totaled 4,707,450 shares, as compared to 1,333,955 shares since October 15, a jump of 252.89%. Average daily volume [AVM] for the same period rose by 5,466,414 to 5,539,750 shares from 73,336 shares.
Based on the latest AVM, the days-to-cover ratio — a metric that includes both the total shares short and the average daily volume of shares traded — is currently 1.00 days. Days-to-cover for RGLS decreased to 1.00 for the October 31 settlement date, as compared to 18.19 days at the October 15 report.
Regulus Therapeutics Inc. has a beta of 1.79 and a short float of 20.20%. In the past 52 weeks, shares of San Diego, California-based company have traded between a low of $5.40 and a high of $25.60 and are now at $20.41. RGLS, currently valued at $981.78M, has a median Wall Street price target of $23.00 with a high target of $34.00. Shares are up 238.91% year-over-year, and 177% year-to-date.